Position in RCEL
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$29,541
+$29,430 QoQ
Shares Held
7,153
+23743.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#44
of 73 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCEL Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Arax Advisory Partners holds $49,649,548 across 86 Medical Devices names. RCEL ranks #58 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
144,198 | $13,084,526 | |
| 2 | SYK |
Stryker Corp
|
17,775 | $5,596,281 | |
| 3 | MDT |
Medtronic plc
|
60,057 | $4,698,259 | |
| 4 | TXG |
10x Genomics, Inc.
|
90,139 | $3,455,929 | |
| 5 | BSX |
Boston Scientific Corp
|
77,337 | $3,300,743 | |
| 6 | ZBH |
Zimmer Biomet Holdings, Inc.
|
34,980 | $3,011,428 | |
| 7 | BRKR |
Bruker Corp
|
49,085 | $2,953,935 | |
| 8 | PODD |
Insulet Corp
|
14,292 | $2,175,957 |
All Filings in RCEL
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,541 | 7,153 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $111 | 30 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $34 | 10 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,253 | 441 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||